Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

505 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling.
Bergamo F, Dalla Santa S, Loupakis F, Cerma K, Tosi A, De Grandis C, Dalla Pietà A, Gringeri E, Angerilli V, Ramondo G, Rago A, Cecchi F, Benz S, Cillo U, Dei Tos AP, Zagonel V, Fassan M, Rosato A, Lonardi S. Bergamo F, et al. Among authors: rosato a. Front Oncol. 2022 Dec 8;12:964219. doi: 10.3389/fonc.2022.964219. eCollection 2022. Front Oncol. 2022. PMID: 36578937 Free PMC article.
Survivin expression impacts prognostically on NSCLC but not SCLC.
Rosato A, Menin C, Boldrin D, Dalla Santa S, Bonaldi L, Scaini MC, Del Bianco P, Zardo D, Fassan M, Cappellesso R, Fassina A. Rosato A, et al. Lung Cancer. 2013 Feb;79(2):180-6. doi: 10.1016/j.lungcan.2012.11.004. Epub 2012 Dec 4. Lung Cancer. 2013. PMID: 23218791
Functional avidity-driven activation-induced cell death shapes CTL immunodominance.
Dalla Santa S, Merlo A, Bobisse S, Ronconi E, Boldrin D, Milan G, Barbieri V, Marin O, Facchinetti A, Biasi G, Dolcetti R, Zanovello P, Rosato A. Dalla Santa S, et al. Among authors: rosato a. J Immunol. 2014 Nov 1;193(9):4704-11. doi: 10.4049/jimmunol.1303203. Epub 2014 Sep 22. J Immunol. 2014. PMID: 25246498
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma.
Mazzocco M, Martini M, Rosato A, Stefani E, Matucci A, Dalla Santa S, De Sanctis F, Ugel S, Sandri S, Ferrarini G, Cestari T, Ferrari S, Zanovello P, Bronte V, Sartoris S. Mazzocco M, et al. Among authors: rosato a. Immunology. 2015 Sep;146(1):33-49. doi: 10.1111/imm.12477. Epub 2015 Jun 15. Immunology. 2015. PMID: 25959091 Free PMC article.
Reverse immunoediting: When immunity is edited by antigen.
Merlo A, Dalla Santa S, Dolcetti R, Zanovello P, Rosato A. Merlo A, et al. Among authors: rosato a. Immunol Lett. 2016 Jul;175:16-20. doi: 10.1016/j.imlet.2016.04.015. Epub 2016 Apr 27. Immunol Lett. 2016. PMID: 27131431 Review.
A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer.
Montagner IM, Merlo A, Carpanese D, Dalla Pietà A, Mero A, Grigoletto A, Loregian A, Renier D, Campisi M, Zanovello P, Pasut G, Rosato A. Montagner IM, et al. Among authors: rosato a. J Control Release. 2016 Aug 28;236:79-89. doi: 10.1016/j.jconrel.2016.06.033. Epub 2016 Jun 26. J Control Release. 2016. PMID: 27356018 Free article.
505 results